3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
7
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, B-Cell
2
Waldenstrom Macroglobulinemia
1
Neoplasms
1
Lymphoma, B-Cell, Marginal Zone
1
Hematologic Neoplasms
1
Interventions
pembrolizumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Gemcitabine
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Bendamustine Hydrochloride
×
30 days
×
Clear all
No trials found.